169059-200
2 January 2019
Pharmablue
Did you like this article? Share on social networks:
2 January 2019
Pharmablue
Did you like this article? Share on social networks:
About the "Exploitant" status French regulatory authorities require having an « Exploitant » authorized and...
Expanded Access is a treatment option that allows the use of an unauthorized medicine (investigational...
Rare diseases: At the core of our mission At PharmaBlue, we’ve spent the past decade...